Here is a response from the company -
..."For your information, the 24 month disc data presented at JP Morgan were simply those as disclosed in the ASX announcement. The presentation was a general corporate overview and was not focused on the disc results, so only the relevant new top line data (per the ASX announcement) were presented. Detailed presentation of the 24 month data will be presented at upcoming academic meetings, and the market will then be informed"...
You can read that as you like - from my perspective ..I note 1 minor point - FDA has a approved the start of the P3 trials.
DYOR - as always !!!!!
Ann: P3 trial initiated, positive 24 mth P2 results in back pain, page-21
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |